您的位置: 首页 > 农业专利 > 详情页

PROCEDES ET COMPOSITIONS COMPRENANT UNE THERAPIE GENIQUE SUPPRESSIVE DE TUMEUR ET DES AGONISTES DE CD122/CD132 POUR LE TRAITEMENT DU CANCER
专利权人:
MULTIVIR INC.
发明人:
SOBOL, ROBERT E.,MENANDER, KERSTIN B.,WIEDERHOLD, DORA,CHADA, SUNIL
申请号:
CA3094329
公开号:
CA3094329A1
申请日:
2019.03.19
申请国别(地区):
CA
年份:
2020
代理人:
摘要:
Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of at least one CD 122/CD 132 agonist, at least one immune checkpoint inhibitor and a viral composition comprising one or more viruses engineered to overexpress a tumor suppressor gene and/or an adenoviral death protein. Also provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of at least one oncolytic viral composition and at least one CD122/CD132 agonist and at least one immune checkpoint inhibitor. Also provided herein are methods of enhancing anti-tumor efficacy by administering the agents described above in combination with other cancer therapies. In highly aggressive forms of cancer, known to be generally resistant to immune therapies, these treatments unexpectedly resulted in complete tumor remissions and curative outcomes.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充